Wegovy · pharmadog

Sign In Subscribe

Wegovy · pharmadog

Patent cliff

source: FDA Orange Book

first barrier falls

Jul 21, 2026

14 days

Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.

patents (165)

Feb 17, 2041formulationUS 11318191
Feb 17, 2041formulationUS 11318191
Feb 17, 2041formulationUS 11318191
Feb 17, 2041formulationUS 11318191
Feb 17, 2041formulationUS 11318191
Feb 17, 2041formulationUS 11318191
May 13, 2040method-of-use (U-3861)US 11478533
May 13, 2040method-of-use (U-3861)US 11478533
May 13, 2040method-of-use (U-3861)US 11478533
May 13, 2040method-of-use (U-3861)US 11478533
May 13, 2040method-of-use (U-3861)US 11478533
Feb 1, 2039formulationUS 11833248
Feb 1, 2039formulationUS 11833248
Feb 1, 2039formulationUS 11833248
Feb 1, 2039formulationUS 11833248
Feb 1, 2039formulationUS 11833248
Feb 1, 2039formulationUS 11833248
Feb 1, 2039formulationUS 11833248
Feb 1, 2039formulationUS 12396953
Feb 1, 2039formulationUS 12396953
Feb 1, 2039formulationUS 12396953
Feb 1, 2039formulationUS 12396953
Feb 1, 2039formulationUS 12396953
Feb 1, 2039formulationUS 12396953
Feb 1, 2039formulationUS 12396953
Oct 10, 2038method-of-use (U-4418)US 12029779
Oct 10, 2038method-of-use (U-3162)US 12029779
Oct 10, 2038method-of-use (U-2628)US 12295988
Oct 10, 2038method-of-use (U-4418)US 12551536
Oct 10, 2038method-of-use (U-4418)US 12551536
Aug 24, 2038formulationUS 10888605
Aug 24, 2038formulationUS 10888605
Aug 24, 2038formulationUS 10888605
Aug 24, 2038formulationUS 10888605
Aug 24, 2038formulationUS 10888605
Aug 24, 2038formulationUS 10888605
Aug 24, 2038formulationUS 11752198
Aug 24, 2038formulationUS 11752198
Aug 24, 2038formulationUS 11752198
Aug 24, 2038formulationUS 11752198
Aug 24, 2038formulationUS 11752198
Aug 24, 2038formulationUS 11752198
Aug 24, 2038formulationUS 12214017
Aug 24, 2038formulationUS 12214017
Aug 24, 2038formulationUS 12214017
Aug 24, 2038formulationUS 12214017
Aug 24, 2038formulationUS 12214017
Aug 24, 2038formulationUS 12214017
Apr 28, 2037method-of-use (U-4443)US 12569543
Apr 28, 2037method-of-use (U-4443)US 12569543
Apr 28, 2037method-of-use (U-4443)US 12569543
Apr 28, 2037method-of-use (U-4443)US 12569543
Apr 28, 2037method-of-use (U-4443)US 12569543
Apr 28, 2037method-of-use (U-4443)US 12569543
Apr 28, 2037method-of-use (U-4446)US 12569543
Apr 28, 2037method-of-use (U-4446)US 12569543
Apr 28, 2037method-of-use (U-4446)US 12569543
May 2, 2034method-of-use (U-4389)US 10278923
May 2, 2034method-of-use (U-4389)US 10278923
May 2, 2034method-of-use (U-4389)US 10278923
May 2, 2034method-of-use (U-4389)US 10278923
May 2, 2034method-of-use (U-2628)US 10278923
May 2, 2034method-of-use (U-2628)US 10278923
May 2, 2034method-of-use (U-2628)US 10278923
May 2, 2034compositionUS 10278923
May 2, 2034compositionUS 10278923
May 2, 2034compositionUS 10278923
May 2, 2034method-of-use (U-4388)US 12239739
May 2, 2034compositionUS 12239739
May 2, 2034compositionUS 12239739
May 2, 2034compositionUS 12239739
May 2, 2034compositionUS 12239739
May 2, 2034compositionUS 12239739
May 2, 2034compositionUS 12239739
May 2, 2034method-of-use (U-4388)US 12239739
May 2, 2034method-of-use (U-4388)US 12239739
May 2, 2034method-of-use (U-4388)US 12239739
May 2, 2034method-of-use (U-2628)US 12514822
May 2, 2034method-of-use (U-2628)US 12514822
May 2, 2034method-of-use (U-2628)US 12514822
May 2, 2034method-of-use (U-2628)US 12514822
May 2, 2034method-of-use (U-2628)US 12514822
May 2, 2034method-of-use (U-2628)US 12514822
Jun 21, 2033formulationUS 10335462
Jun 21, 2033method-of-use (U-2580)US 10335462
Jun 21, 2033method-of-use (U-2580)US 10335462
Jun 21, 2033method-of-use (U-3161)US 9764003
Jun 21, 2033method-of-use (U-3161)US 9764003
Jun 21, 2033method-of-use (U-3161)US 9764003
Jun 21, 2033method-of-use (U-3161)US 9764003
Jun 21, 2033method-of-use (U-4418)US 9764003
Jun 21, 2033method-of-use (U-3161)US 9764003
Mar 15, 2033formulationUS 10933120
Mar 15, 2033formulationUS 10933120
Mar 15, 2033formulationUS 10933120
Mar 15, 2033formulationUS 11759501
Mar 15, 2033formulationUS 11759501
Mar 15, 2033formulationUS 11759501
Mar 15, 2033formulationUS 11759502
Mar 15, 2033formulationUS 11759502
Mar 15, 2033formulationUS 11759502
Mar 15, 2033formulationUS 11759503
Mar 15, 2033formulationUS 11759503
Mar 15, 2033formulationUS 11759503
Dec 16, 2031formulationUS 10086047
Dec 16, 2031formulationUS 10086047
Dec 16, 2031formulationUS 10086047
Dec 16, 2031formulationUS 10960052
Dec 16, 2031formulationUS 10960052
Dec 16, 2031formulationUS 10960052
Dec 16, 2031compositionUS 11382957
Dec 16, 2031formulationUS 11382957
Dec 16, 2031formulationUS 11382957
Dec 16, 2031formulationUS 11382957
Dec 16, 2031compositionUS 11382957
Dec 16, 2031formulationUS 11382957
Dec 16, 2031compositionUS 11382957
Dec 16, 2031formulationUS 11382957
Dec 16, 2031formulationUS 11382957
Dec 16, 2031formulationUS 11382957
Dec 16, 2031formulationUS 9278123
Dec 16, 2031compositionUS 9278123
Dec 16, 2031formulationUS 9278123
Dec 16, 2031formulationUS 9278123
Dec 16, 2031formulationUS 9278123
Dec 16, 2031formulationUS 9278123
Dec 5, 2031compositionUS 8129343
Dec 5, 2031compositionUS 8129343
Dec 5, 2031compositionUS 8129343
Dec 5, 2031compositionUS 8129343
Dec 5, 2031compositionUS 8129343
Dec 5, 2031compositionUS 8129343
Dec 5, 2031compositionUS 8129343
Dec 5, 2031compositionUS 8129343
Dec 5, 2031compositionUS 8129343
Dec 5, 2031compositionUS 8129343
Dec 5, 2031compositionUS 8129343
Dec 5, 2031compositionUS 8129343
Dec 5, 2031compositionUS 8129343
Dec 5, 2031compositionUS 8129343
Dec 5, 2031compositionUS 8129343
Dec 5, 2031compositionUS 8129343
Dec 5, 2031compositionUS 8129343
Dec 5, 2031compositionUS 8129343
Dec 5, 2031compositionUS 8129343
Dec 5, 2031compositionUS 8129343
Mar 20, 2026compositionUS 8536122
Mar 20, 2026compositionUS 8536122
Mar 20, 2026compositionUS 8536122
Mar 20, 2026compositionUS 8536122
Mar 20, 2026compositionUS 8536122
Mar 20, 2026compositionUS 8536122
Mar 20, 2026compositionUS 8536122
Mar 20, 2026compositionUS 8536122
Mar 20, 2026compositionUS 8536122
Mar 20, 2026compositionUS 8536122
Mar 20, 2026compositionUS 8536122
Mar 20, 2026compositionUS 8536122
Mar 20, 2026compositionUS 8536122
Mar 20, 2026compositionUS 8536122
Mar 20, 2026compositionUS 8536122
Mar 20, 2026compositionUS 8536122
Mar 20, 2026compositionUS 8536122
Mar 20, 2026compositionUS 8536122
Mar 20, 2026compositionUS 8536122

FDA exclusivities (29)

Dec 22, 2028NPNP2.5y
Dec 22, 2028NPNP2.5y
Dec 22, 2028NPNP2.5y
Dec 22, 2028NPNP2.5y
Oct 17, 2028I-976Indication (3y)2.3y
Oct 17, 2028I-976Indication (3y)2.3y